| A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ... Nature genetics 47 (9), 1079-1084, 2015 | 258 | 2015 |
| Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity F Aminkeng, CJD Ross, SR Rassekh, S Hwang, MJ Rieder, AP Bhavsar, ... British journal of clinical pharmacology 82 (3), 683-695, 2016 | 218 | 2016 |
| The emerging era of pharmacogenomics: current successes, future potential, and challenges JW Lee, F Aminkeng, AP Bhavsar, K Shaw, BC Carleton, MR Hayden, ... Clinical genetics 86 (1), 21-28, 2014 | 98 | 2014 |
| Unbiased profiling of isogenic Huntington disease hPSC-derived CNS and peripheral cells reveals strong cell-type specificity of CAG length effects J Ooi, SR Langley, X Xu, KH Utami, B Sim, Y Huang, NP Harmston, ... Cell Reports 26 (9), 2494-2508. e7, 2019 | 72 | 2019 |
| The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population C Kay, JA Collins, GEB Wright, F Baine, Z Miedzybrodzka, F Aminkeng, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018 | 69 | 2018 |
| Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ... Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019 | 67 | 2019 |
| Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ... JAMA oncology 3 (11), 1558-1562, 2017 | 57 | 2017 |
| Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients SL Chan, APG Chua, F Aminkeng, CBE Chee, S Jin, M Loh, SH Gan, ... PLoS One 12 (10), e0186200, 2017 | 54 | 2017 |
| Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent F Aminkeng, CJD Ross, SR Rassekh, LR Brunham, J Sistonen, MP Dube, ... The pharmacogenomics journal 14 (2), 160-170, 2014 | 45 | 2014 |
| Neutrophil-to-lymphocyte ratio predicts development of immune-related adverse events and outcomes from immune checkpoint blockade: a case-control study PY Lee, KQX Oen, GRS Lim, JL Hartono, M Muthiah, DQ Huang, ... Cancers 13 (6), 1308, 2021 | 43 | 2021 |
| CPNDS Clinical Practice Recommendations Group. Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity F Aminkeng, CJ Ross, SR Rassekh, S Hwang, MJ Rieder, AP Bhavsar, ... Br J Clin Pharmacol 82 (3), 683-695, 2016 | 41 | 2016 |
| Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study D Nanfa, E Sobngwi, B Atogho-Tiedeu, JJN Noubiap, OS Donfack, ... Clinical and translational medicine 4, 1-5, 2015 | 41 | 2015 |
| Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon M Guewo-Fokeng, E Sobngwi, B Atogho-Tiedeu, OS Donfack, ... Journal of Diabetes & Metabolic Disorders 14, 1-5, 2015 | 38 | 2015 |
| Cytokine release syndrome in cancer patients receiving immune checkpoint inhibitors: a case series of 25 patients and review of the literature SH Tay, MMX Toh, YL Thian, BA Vellayappan, AM Fairhurst, YH Chan, ... Frontiers in immunology 13, 807050, 2022 | 37 | 2022 |
| Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis K Kowalec, GEB Wright, BI Drögemöller, F Aminkeng, AP Bhavsar, ... Nature genetics 50 (8), 1081-1085, 2018 | 37 | 2018 |
| IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype–phenotype correlation in the Belgian population F Aminkeng, JE Van Autreve, I Weets, E Quartier, C Van Schravendijk, ... Human immunology 70 (9), 706-710, 2009 | 25 | 2009 |
| Risk factors for immune‐related adverse events from anti‐PD‐1 or anti‐PD‐L1 treatment in an Asian cohort of nonsmall cell lung cancer patients Y Huang, YY Soon, F Aminkeng, SH Tay, Y Ang, ACL Kee, BC Goh, ... International Journal of Cancer 150 (4), 636-644, 2022 | 23 | 2022 |
| Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA‐C1 ligand binding E Ramos‐Lopez, F Scholten, F Aminkeng, C Wild, H Kalhes, C Seidl, ... Tissue Antigens 73 (6), 599-603, 2009 | 23 | 2009 |
| MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ JE Van Autreve, BPC Koeleman, E Quartier, F Aminkeng, I Weets, ... Human immunology 67 (1-2), 94-101, 2006 | 23 | 2006 |
| Pharmacogenomic screening for anthracycline‐induced cardiotoxicity in childhood cancer F Aminkeng, CJD Ross, SR Rassekh, MJ Rieder, AP Bhavsar, S Sanatani, ... British journal of clinical pharmacology 83 (5), 1143, 2017 | 20 | 2017 |
